Evidence map›Paper›PMID 39741445›Full record

ArticleThe American journal of psychiatry2025

Psychedelic Regulation Beyond the Controlled Substances Act: A Three-Dimensional Framework for Characterizing Policy Options.

Maha N Mian, Michael T Dinh, Allison R Coker, Jennifer M Mitchell, Brian T Anderson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The American journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.The international journal of neuropsychopharmacology · 2026
    Review
  3. Article
  4. Psychedelic therapeutics in psychiatric conditions.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maha N MianDepartment of Psychology, Suffolk University, Boston, Mass. (Mian); Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco (Mian, Dinh, Mitchell, Anderson); Kaiser Permanente Northern California, Division of Research, Oakland, Calif. (Mian); Department of Psychology, Suffolk University, Boston (Mian); Department of Neurology, University of California San Francisco, San Francisco (Coker, Mitchell); Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, Calif. (Coker); Department of Veterans Affairs, Research Service, San Francisco VA Medical Center, San Francisco (Mitchell); UC Berkeley Center for the Science of Psychedelics, Berkeley, Calif. (Mitchell, Anderson).
Michael T DinhDepartment of Psychology, Suffolk University, Boston, Mass. (Mian); Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco (Mian, Dinh, Mitchell, Anderson); Kaiser Permanente Northern California, Division of Research, Oakland, Calif. (Mian); Department of Psychology, Suffolk University, Boston (Mian); Department of Neurology, University of California San Francisco, San Francisco (Coker, Mitchell); Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, Calif. (Coker); Department of Veterans Affairs, Research Service, San Francisco VA Medical Center, San Francisco (Mitchell); UC Berkeley Center for the Science of Psychedelics, Berkeley, Calif. (Mitchell, Anderson).
Allison R CokerDepartment of Psychology, Suffolk University, Boston, Mass. (Mian); Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco (Mian, Dinh, Mitchell, Anderson); Kaiser Permanente Northern California, Division of Research, Oakland, Calif. (Mian); Department of Psychology, Suffolk University, Boston (Mian); Department of Neurology, University of California San Francisco, San Francisco (Coker, Mitchell); Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, Calif. (Coker); Department of Veterans Affairs, Research Service, San Francisco VA Medical Center, San Francisco (Mitchell); UC Berkeley Center for the Science of Psychedelics, Berkeley, Calif. (Mitchell, Anderson).
Jennifer M MitchellDepartment of Psychology, Suffolk University, Boston, Mass. (Mian); Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco (Mian, Dinh, Mitchell, Anderson); Kaiser Permanente Northern California, Division of Research, Oakland, Calif. (Mian); Department of Psychology, Suffolk University, Boston (Mian); Department of Neurology, University of California San Francisco, San Francisco (Coker, Mitchell); Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, Calif. (Coker); Department of Veterans Affairs, Research Service, San Francisco VA Medical Center, San Francisco (Mitchell); UC Berkeley Center for the Science of Psychedelics, Berkeley, Calif. (Mitchell, Anderson).
Brian T AndersonDepartment of Psychology, Suffolk University, Boston, Mass. (Mian); Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco (Mian, Dinh, Mitchell, Anderson); Kaiser Permanente Northern California, Division of Research, Oakland, Calif. (Mian); Department of Psychology, Suffolk University, Boston (Mian); Department of Neurology, University of California San Francisco, San Francisco (Coker, Mitchell); Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, Calif. (Coker); Department of Veterans Affairs, Research Service, San Francisco VA Medical Center, San Francisco (Mitchell); UC Berkeley Center for the Science of Psychedelics, Berkeley, Calif. (Mitchell, Anderson).

Funding

Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
NIDA NIH HHS T32 DA007250
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39741445
PMCPMC11772052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.